NR3C2 and apparent mineralocorticoid excess: The mutations inHSD11B2 result in a high circulating level of cortisol, and further illegitimate activation of the mineralocorticoid receptor, outcompeting aldosterone and causing activation of the downstream pathways and a clinical presentation of AME symptoms.